Authors/Disclosures
|
Christopher J. Klein, MD, FÂ鶹´«Ã½Ó³»
(Mayo Clinic)
|
Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. |
|
|
No disclosure on file |
|
Christopher M. DeGiorgio, MD, FÂ鶹´«Ã½Ó³»
(UCLA Department of Neurology At Olive View)
|
Dr. DeGiorgio has received intellectual property interests from a discovery or technology relating to health care. |
|
Sean J. Pittock, MD, FÂ鶹´«Ã½Ó³»
(Mayo Clinic Dept of Neurology)
|
Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
JaNean Engelstad
|
JaNean Engelstad has nothing to disclose. |
|
|
No disclosure on file |
|
Sean Taylor, MD
(Dalhousie University & Nova Scotia Health Authority)
|
No disclosure on file |
|
Peter J. Dyck, MD, FÂ鶹´«Ã½Ó³»
(Mayo Clinic)
|
Dr. Dyck has nothing to disclose. |
|
John L. Berk
|
John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca/IONIS. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eidos/BridgBio. John L. Berk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia Therapeutics. John L. Berk has received research support from Alnylam . John L. Berk has received research support from Ionis. John L. Berk has received research support from Eidos/Bridgbio. |